https://www.selleckchem.com/products/gdc-0068.html
The validation of a putative leishmanial InhA orthologue as a therapeutic target needs to be further investigated.In December 2019, an infectious disease was detected in Wuhan, China, caused by a new pathogenic coronavirus, named SARS-CoV-2. It spread very rapidly, and on March 11th of 2020, the outbreak was declared a pandemic by the World Health Organization. Currently, effective treatment options remain limited. SARS-CoV-2 enzyme main protease (MPRO) plays a pivotal role in the viral life cycle, making it a putative drug target. In
Like
Comment
Share
